Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production

Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, is pleased to announce that it has closed on an important land purchase in Wallonia, Belgium, and signed a purchase agreement to build a state-of-the-art, manufacturing facility to produce radiopharmaceuticals to Good Manufacturing Practice (GMP) standards.

“Production capability and capacity, as well as logistics challenges have been major bottlenecks to radiotherapeutic discovery and development,” said Philippe van Put, General Manager of Full-Life Technology Europe. “The advanced GMP manufacturing facility we are building at this 17,000 square meter site, will provide us with an internal, integrated manufacturing solution and a strong competitive advantage.” He noted that Wallonia in Belgium was selected for its strategic geographic location, advanced infrastructure, and excellent transportation network.

The region is a leading hub for radiopharmaceutical production, and Full-Life will leverage its expertise and the local ecosystem to accelerate the facility’s construction and GMP drug production.